216 related articles for article (PubMed ID: 32092124)
21. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
Saha A; Halder S; Upadhyay SK; Lu J; Kumar P; Murakami M; Cai Q; Robertson ES
PLoS Pathog; 2011 Feb; 7(2):e1001275. PubMed ID: 21347341
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
[TBL] [Abstract][Full Text] [Related]
23. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.
Knight JS; Sharma N; Kalman DE; Robertson ES
J Virol; 2004 Dec; 78(23):12857-67. PubMed ID: 15542638
[TBL] [Abstract][Full Text] [Related]
24. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency.
Styles CT; Bazot Q; Parker GA; White RE; Paschos K; Allday MJ
PLoS Biol; 2017 Aug; 15(8):e2001992. PubMed ID: 28771465
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.
Knight JS; Lan K; Subramanian C; Robertson ES
J Virol; 2003 Apr; 77(7):4261-72. PubMed ID: 12634383
[TBL] [Abstract][Full Text] [Related]
26. EBV persistence without its EBNA3A and 3C oncogenes in vivo.
Murer A; McHugh D; Caduff N; Kalchschmidt J; Barros M; Zbinden A; Capaul R; Niedobitek G; Allday M; Chijioke O; Münz C
PLoS Pathog; 2018 Apr; 14(4):e1007039. PubMed ID: 29709016
[TBL] [Abstract][Full Text] [Related]
27. EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation.
Pei Y; Banerjee S; Sun Z; Jha HC; Saha A; Robertson ES
PLoS Pathog; 2016 Aug; 12(8):e1005844. PubMed ID: 27548379
[TBL] [Abstract][Full Text] [Related]
28. EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.
Saha A; Bamidele A; Murakami M; Robertson ES
J Virol; 2011 Mar; 85(5):2079-88. PubMed ID: 21177815
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.
Bajaj BG; Murakami M; Cai Q; Verma SC; Lan K; Robertson ES
J Virol; 2008 Apr; 82(8):4082-90. PubMed ID: 18256156
[TBL] [Abstract][Full Text] [Related]
30. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
Shukla SK; Jha HC; El-Naccache DW; Robertson ES
Oncotarget; 2016 Apr; 7(14):18116-34. PubMed ID: 26908453
[TBL] [Abstract][Full Text] [Related]
31. Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.
Cotter MA; Robertson ES
Mol Cell Biol; 2000 Aug; 20(15):5722-35. PubMed ID: 10891508
[TBL] [Abstract][Full Text] [Related]
32. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
Jha HC; Lu J; Saha A; Cai Q; Banerjee S; Prasad MA; Robertson ES
J Virol; 2013 Nov; 87(22):12121-38. PubMed ID: 23986604
[TBL] [Abstract][Full Text] [Related]
33. Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5.
Pokrovskaja K; Mattsson K; Kashuba E; Klein G; Szekely L
J Gen Virol; 2001 Feb; 82(Pt 2):345-358. PubMed ID: 11161273
[TBL] [Abstract][Full Text] [Related]
34. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).
Robertson ES; Lin J; Kieff E
J Virol; 1996 May; 70(5):3068-74. PubMed ID: 8627785
[TBL] [Abstract][Full Text] [Related]
35. p62-mediated Selective autophagy endows virus-transformed cells with insusceptibility to DNA damage under oxidative stress.
Wang L; Howell MEA; Sparks-Wallace A; Hawkins C; Nicksic CA; Kohne C; Hall KH; Moorman JP; Yao ZQ; Ning S
PLoS Pathog; 2019 Apr; 15(4):e1007541. PubMed ID: 31017975
[TBL] [Abstract][Full Text] [Related]
36. Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux.
Kim HJ; Kim SY; Kim DH; Park JS; Jeong SH; Choi YW; Kim CH
Autophagy; 2021 Apr; 17(4):961-979. PubMed ID: 32164484
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
Cai Q; Guo Y; Xiao B; Banerjee S; Saha A; Lu J; Glisovic T; Robertson ES
PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells.
Touitou R; O'Nions J; Heaney J; Allday MJ
J Gen Virol; 2005 May; 86(Pt 5):1269-1277. PubMed ID: 15831937
[TBL] [Abstract][Full Text] [Related]
39. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ
PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997
[TBL] [Abstract][Full Text] [Related]
40. High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.
Coppotelli G; Mughal N; Marescotti D; Masucci MG
J Biol Chem; 2011 Jun; 286(22):19565-75. PubMed ID: 21471195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]